Epoch 12 - Biotech Are We In the Eye of the Storm?

Exploring Near Term Catalysts

Hello Avatar!  Welcome to another week of biotech analysis.  Pretty slow week in terms of significant news flow.  On the public side, XBI slowly continues its recovery. On the private side, not much has caught our attention this week.  Personally, we have been head down pushing deals forward, maybe this is the same situation for our colleagues and it is…